What's New
FTD in the News
Arkuda Therapeutics Secures Funding for FTD-GRN Research
Biotechnology company Arkuda Therapeutics recently acquired multi-million dollar funding to continue its research program targeted at increasing…
Atlanta TV News Segment Examines Impact of FTD and other Dementias on Black Communities
A couple living in Atlanta shared their experience of living with FTD in a local TV news…
Study Reveals How Tau Proteins Found in FTD and other Neurodegenerative Disorders Affect Cell Interaction
Researchers from the Buck Institute for Research on Aging have gained new insight into how the protein…
“New York Times” Article Examines Prevalence Rate and Diagnostic Challenges of Young-Onset Dementia
The New York Times highlighted a recent study underlining the high prevalence rate of young-onset dementia and…
New Pharma-Academic Partnership Aims to Advance FTD Treatment Development
Pharmaceutical company GlaxoSmithKline (GSK) and the University of Oxford have teamed up to further advance research and…
Researchers Gather Recommendations of Practical Treatments to Support Persons with svPPA
Investigators have compiled recommendations for non-pharmacological therapy treatments for persons diagnosed with semantic variant primary progressive aphasia…
Texas Family Raises FTD Awareness at 2021 BMW Dallas Marathon
More than 17,000 participants competed in the 50th anniversary of the BMW Dallas Marathon, and for some…
Newly Developed Apps Detect Speech Changes Associated with FTD
Researchers have developed apps that use artificial intelligence to detect subtle speech changes that may suggest the…